Guillain-Barre Syndrome
NEJM 366:2294-2304, Yuki, N. & Hartung, H.P., 2012
Guillain-Barre Syndrome
Lancet 366:1653-1666, Hughes,R.C. &Comblath,D.R., 2005
Outcome in Severe Pediatric Guillain-Barre Syndrome after Immunotherapy or Supportive Care
Neurol 52:1494-1497, Graf,W.D.,et al, 1999
Prognostic Factors of Guillain-Barre Syndrome After Intravenous Immunoglobulin or Plasma Exchange?
Neurol 53:598-604, Visser,L.H.,et al, 1999
Campylobacter Jejuni Infection and Anti-GM1 Antibodies in Guillain-Barre Syndrome
Ann Neurol 40:181-187, Jacobs,B.C.,et al, 1996
Intensive Management and Treatment of Severe Guillain-Barre Syndrome
Crit Care Med 21:433-446, Hund,E.F.,et al, 1993
Plasmapheresis in Children with Guillain-Barre Syndrome
Neurol 41:1928-1931, Lamont,P.J.,et al, 1991
Plasmapheresis and Guillain-Barre Syndrome:Analysis of Prognostic Factors & the Effect of Plasmapheresis
Ann Neurol 23:347-353, McKhann,G.M.,et al, 1988
Guillain-Barre Syndrome:Quantitative Measurement of Plasma Exchange Therapy
Neurol 37:837-840, Farkkila,M.,et al, 1987